Summary by Moomoo AI
Clearmind Medicine Inc. has announced the pricing of a registered direct offering and concurrent private placement on January 11, 2024. The company entered into a securities purchase agreement with investors for the sale of 1,468,000 common shares and pre-funded warrants to purchase up to 32,000 common shares. Additionally, in a private placement, Clearmind Medicine agreed to issue 1,500,000 common warrants, exercisable at $1.60 per share with a 5-year term. The offerings are priced at $1.60 per ordinary share and associated PIPE Warrant, and $1.5999 for each Pre-Funded Warrant and associated PIPE Warrant. The transactions are expected to close on January 16, 2024, with anticipated gross proceeds of approximately $2.4 million. The company also entered into a registration rights agreement, committing to file a resale registration statement for the common...Show More